Video: Abbott Buys Solvay's Drug Unit

Abbott Laboratories (ABT) has agreed to buy the drug unit of Belgian firm Solvay for $6.6 billion in cash. The deal could include additional milestone payments and liabilities later on.

Watch now:

Watch more from the markets now:

Bookmark Market News Live and drop back whenever you need to stay ahead of today's markets.